Barasa E


93 results

Cost-effectiveness of community health systems strengthening: quality improvement interventions at community level to realise maternal and child health gains in Kenya.Kumar MB, Madan JJ, Auguste P, Taegtmeyer M, Otiso L, Ochieng CB, Muturi N, Mgamb E, Barasa E
BMJ Glob Health, (2021). 6:e002452

Collective sensemaking for action: researchers and decision makers working collaboratively to strengthen health systems.Gilson L, Barasa E, Brady L, Kagwanja N, Nxumalo N, Nzinga J, Molyneux S, Tsofa B
BMJ, (2021). 372:m4650

Unit costs and other musings: a response.Torres-Rueda S, Ferrari G, Orangi S, Hitimana R, Daviaud E, Tawiah T, Prah RKD, Karmaliani R, Kapapa E, Barasa E, Jewkes R, Vassall A
Health Policy Plan, (2021). 36:223-225

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.Uyoga S, Adetifa IMO, Karanja HK, Nyagwange J, Tuju J, Wanjiku P, Aman R, Mwangangi M, Amoth P, Kasera K, Ng'ang'a W, Rombo C, Yegon C, Kithi K, Odhiambo E, Rotich T, Orgut I, Kihara S, Otiende M, Bottomley C, Mupe ZN, Kagucia EW, Gallagher KE, Etyang A, Voller S, Gitonga JN, Mugo D, Agoti CN, Otieno E, Ndwiga L, Lambe T, Wright D, Barasa E, Tsofa B, Bejon P, Ochola-Oyier LI, Agweyu A, Scott JAG, Warimwe GM
Science, (2021). 371:79-82

Prevalence of anti-SARS-CoV-2 IgG antibodies among Kenyan blood donors between June and August 2021..Uyoga S, Otiende M, Adetifa IMO, Karanja HK, Gitonga J, Mugo D, Makale J, Tawa B, Singilai A, Nyagwange J, Tuju J, Aman R, Mwangangi M, Amoth P, Kasera K, Ng’ang’a W, Kilonzo N, Chege E, Yegon C, Rotich T, Orgut I, Kagucia EW, Gallagher KE, Etyang A, Voller S, Bottomley C, Lambe T, Wright D, Tsofa B, Mwangangi J, Barasa E, Bejon P, Ochola-Oyier LI, Warimwe GM, Scott JAG, Agweyu A
1st International Conference on Public Health in Africa (CPHIA), (2021). :

High anti-SARS-CoV-2 IgG antibody seroprevalence among long-distance trucking crews in Kenya within one year of the COVID-19 pandemic..Kagucia EW, Gitonga JN, Kalu C, Kuya N, Ochieng B, Karia B, Ochomo E, Karani A, Nyagwange J, Mugo D, Karanja HK, Tuju J, Mutiso A, Maroko H, Okubi L, Maitha E, Mukabi D, The TDA SARS-CoV-2 Serosurveillance Team, Aman R, Mwangangi M, Amoth P, Kasera K, Ng’ang’a W, Nyaguara A, Voller S, Otiende M, Bottomley C, Agoti CN, Ochola-Oyier LI, Adetifa IMO, Etyang AO, Gallagher KE, Uyoga S, Barasa E, Bejon P, Tsofa B, Agweyu A, Warimwe GM, Scott JAG
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Experiences and response to the coronavirus disease 2019 (COVID 19) pandemic at private retail pharmacies in Kenya, 2020: a mixed methods study.Mugo P, Mumbi A, Munene D, Nzinga J, Molyneux S, Barasa E, on behalf of PSK CRT
1st International Conference on Public Health in Africa (CPHIA-2021), (2021). :

Serosurveillance for SARS-CoV-2 Antibodies in a cohort of Health Care Workers in Kenya..Etyang AO, Lucinde R, Gitonga JN, Kalu C, Karani A, Nyagwange J, Mugo D, Karanja HK, Tuju J, Mutiso A, Maroko H, Okubi L, Maitha E, Mukabi D, The HCW SARS-CoV-2 Serosurveillance Team, Aman R, Mwangangi M, Amoth P, Kasera K, Ng’ang’a W, Nyaguara A, Voller S, Otiende M, Bottomley C, Agoti CN, Ochola-Oyier LI, Adetifa IMO, Gallagher KE, Uyoga S, Barasa E, Bejon P, Tsofa B, Agweyu A, Warimwe GM, Scott JAG
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Genomic surveillance of SARS-CoV-2 in Kenya: March 2020-October 2021..Githinji G, Lambisia WA, Mohamed KS, Morobe MJ, de Laurent ZR, Mburu WM, Ongera ME, Omuoyo OD, Ndwiga L, Otieno E, Murunga N, Musyoki J, KWTRP COVID Testing Team, Kilifi Rapid Response Team, Kiiru J, Kasera K, Amoth P, Mwangangi M, Aman R, Kinyanjui S, Warimwe GM, Agweyu A, Barasa E, Tsofa B, Mwangangi J, Matoke D, Nokes DJ, Bejon P, Ochola-Oyier LI, Agoti CN
1st International Conference on Public Health in Africa (CPHIA-2021), (2021). :

All-cause and cause-specific mortality in Kilifi Health and Demographic Surveillance System, in Kenya in the period of the COVID-19 pandemic..Otiende M, Nyagura A, Bottomley C, Walumbe D, Mochama G, Amadi D, Nyundo C, Kagucia W, Etyang AO, Adetifa IMO, Maitha E, Chondo E, Nzomo E, Aman R, Mwangangi M, Amoth P, Wangari N, Barasa E, Mwangangi J, Bejon P, Agweyu A, Williams TN, Scott JAG
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries.Vassall A, Sweeney S, Barasa E, Prinja S, Keogh-Brown MR, Tarp Jensen H, Smith R, Baltussen R, MEggo R Jit M
Wellcome Open Res, (2020). 5:272

What role can health policy and systems research play in supporting responses to COVID-19 that strengthen socially just health systems?.Gilson L, Marchal B, Ayepong I, Barasa E, Dossou JP, George A, Guinaran R, Maceira D, Molyneux S, Prashanth NS, Schneider H, Shawar Y, Shiffman JR, Sheikh K, Spicer N, Van Belle S, Whyle E
Health Policy Plan, (2020). 35:1231-1236

The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements.Quaife M, van Zandvoort K, Gimma A, Shah K, McCreesh N, Prem K, Barasa E, Mwanga D, Kangwana B, Pinchoff J, CMMID COVID- Working Group, Edmunds WJ, Jarvis CI, Austrian K
BMC Med, (2020). 18:316

Tracking health sector priority setting processes and outcomes for human resources for health, five-years after political devolution: a county-level case study in Kenya.Munywoki J, Kagwanja N, Chuma J, Nzinga J, Barasa E, Tsofa B
Int J Equity Health, (2020). 19:165

SEEP-CI: A Structured Economic Evaluation Process for Complex Health System Interventions.Madan J, Bruce Kumar M, Taegtmeyer M, Barasa E, Singh SP
Int J Environ Res Public Health, (2020). 17:

Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.Dawa J, Emukule GO, Barasa E, Widdowson MA, Anzala O, van Leeuwen E, Baguelin M, Chaves SS, Eggo RM
BMC Med, (2020). 18:223

Systems and implementation science should be part of the COVID-19 response in low resource settings.English M, Moshabela M, Nzinga J, Barasa E, Tsofa B, Marchal B, Kruk ME
BMC Med, (2020). 18:219

What will it cost to prevent violence against women and girls in low- and middle-income countries? Evidence from Ghana, Kenya, Pakistan, Rwanda, South Africa and Zambia.Torres-Rueda S, Ferrari G, Orangi S, Hitimana R, Daviaud E, Tawiah T, Prah RKD, Karmaliani R, Kapapa E, Barasa E, Jewkes R, Vassall A
Health Policy Plan, (2020). 35:855-866

Preferences of healthcare providers for capitation payment in Kenya: a discrete choice experiment.Obadha M, Chuma J, Kazungu J, Abiiro GA, Beck MJ, Barasa E
Health Policy Plan, (2020). 35:842-854

How do decision-makers use evidence in community health policy and financing decisions? A qualitative study and conceptual framework in four African countries.Kumar MB, Taegtmeyer M, Madan J, Ndima S, Chikaphupha K, Kea A, Barasa E
Health Policy Plan, (2020). 35:799-809